Thursday, April 7, 2011

Analyst Actions: CRM, APC, ELN, TZOO, MDRX (NYSE: CRM): FBR Capital on Thursday upgraded its rating on the company to Outperform from Market Perform. The firm lifted its price target on the stock to $170 from $155. In a researcn note to clients, the firm wrote, "The main reason for our upgrade is our revised bullish view on the company's diversification efforts. While much of the company's historical strength has been driven by its sales-force automation (SFA) business, we believe its diversification efforts-which got off to a slow start-are now gaining real traction."

Anadarko Petroleum Corporation (NYSE: APC): Lazard Capital upgraded Anadarko with a $100 price target citing higher oil price and production growth forecasts. 

Elan Corp (NYSE: ELN): RBC Capital this morning upgraded its rating on the stock to Outperform from Sector Perform.The firm raised its price target on the stock to $10 from $8.

Travelzoo (NASDAQ: TZOO): Benchmark Co. lowered its rating on the company to Hold from Buy, citing valuation. In a research note to client, the firm said "While we remain confident that Travelzoo's Local Deals has ramped nicely so far this year and may flourish in 2011, we fear that the stock may have overly reflected the potential contribution from Local Deals too quickly. Similar to the pullback that followed the in-line 4Q10 EPS report, we suspect TZOO stock may temporarily correct around the time of the 1Q11 EPS report which should be released within weeks."

Allscripts Healthcare Solutions Inc (NASDAQ: MDRX): Auriga on Thursday downgrade the company to Hold from Buy. The firm cut its price target on the company to $24 from $25.

Full Disclosure: None.
Related Posts with Thumbnails

Wikinvest Wire